Cita APA

Nautiyal, J., Yu, Y., Aboukameel, A., Kanwar, S., Das, J. K., Du, J., . . . Majumdar, A. P. N. (2010). ErbB Inhibitory Protein [EBIP]: A Modified Ectodomain of EGFR Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells.

Chicago Style Citation

Nautiyal, Jyoti, et al. ErbB Inhibitory Protein [EBIP]: A Modified Ectodomain of EGFR Synergizes With Dasatinib to Inhibit Growth of Breast Cancer Cells. 2010.

Cita MLA

Nautiyal, Jyoti, et al. ErbB Inhibitory Protein [EBIP]: A Modified Ectodomain of EGFR Synergizes With Dasatinib to Inhibit Growth of Breast Cancer Cells. 2010.